FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio Ballesta

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Case Control Studies

Co-author Network

Publications

TOP 3
Sergi Mas; M Jose Lafuente; Anna Crescenti; Manuel Trias; Antonio M Ballesta; Rafael Molina; Shichun Zheng; John K Wiencke; Amalia Lafuente
Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
Sergi Mas; Anna Crescenti; Patricia Gassó; Ramon Deulofeu; Rafael Molina; Antonio M Ballesta; Thomas W Kensler; Amalia Lafuente
Induction of apoptosis in HT-29 cells by extracts from isothiocyanates-rich varieties of Brassica oleracea.
Sergi Mas; Anna Crescenti; Jose M Vidal-Taboada; Salvador Bergoñon; Fernando Cuevillas; Nuria Laso; Rafael Molina; Antonio M Ballesta; Amalia Lafuente
Simultaneous genotyping of CYP2C9*2, *3, and 5' flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio Ballesta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Sergi Mas; M Jose Lafuente; Anna Crescenti; Manuel Trias; Antonio M Ballesta; Rafael Molina; Shichun Zheng; John K Wiencke; Amalia Lafuente
Lower specific micronutrient intake in colorectal cancer patients with tumors presenting promoter hypermethylation in p16(INK4a), p4(ARF) and hMLH1.
Anticancer research 2007;27(2):1151-6.
2007: Sergi Mas; Anna Crescenti; Patricia Gassó; Ramon Deulofeu; Rafael Molina; Antonio M Ballesta; Thomas W Kensler; Amalia Lafuente
Induction of apoptosis in HT-29 cells by extracts from isothiocyanates-rich varieties of Brassica oleracea.
Nutrition and cancer 2007;58(1):107-14.
2005: Sergi Mas; Anna Crescenti; Jose M Vidal-Taboada; Salvador Bergoñon; Fernando Cuevillas; Nuria Laso; Rafael Molina; Antonio M Ballesta; Amalia Lafuente
Simultaneous genotyping of CYP2C9*2, *3, and 5' flanking region (C-1189T) polymorphisms in a Spanish population through a new minisequencing multiplex single-base extension analysis.
European journal of clinical pharmacology 2005;61(9):635-41.
2005: Jose M Auge; Rafael Molina; Xavier Filella; E Bosch; M Gonzalez Cao; Susana Puig; Josep Malvehy; Teresa Castel; Antonio M Ballesta
S-100beta and MIA in advanced melanoma in relation to prognostic factors.
Anticancer research 2005;25(3A):1779-82.
2005: Rafael Molina; Jose M Auge; Xavier Filella; Núria Viñolas; Julian Alicarte; Jose M Domingo; Antonio M Ballesta
Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
Anticancer research 2005;25(3A):1773-8.
2005: Nuria Laso; Sergi Mas; M Jose Lafuente; Joan M Llobet; Rafael Molina; Antonio M Ballesta; Thomas W Kensler; Amalia Lafuente
Induction of NAD(P)H quinone oxidoreductase by vegetables widely consumed in Catalonia, Spain.
Nutrition and cancer 2005;52(1):49-58.
2005: Inmaculada Ros; Luisa Alvarez; Nuria Guañabens; Pilar Peris; Ana Monegal; Ivonne Vázquez; Dacia Cerdá; Antonio M Ballesta; José Muñoz-Gómez
Hypophosphatemic osteomalacia: a report of five cases and evaluation of bone markers.
Journal of bone and mineral metabolism 2005;23(3):266-9.
2004: Xavier Filella; David Truan; Juan Alcover; Rafael Gutierrez; Rafael Molina; Francisca Coca; Antonio M Ballesta
Complexed prostate-specific antigen for the detection of prostate cancer.
Anticancer research 2004;24(6):4181-5.
2004: Luisa Alvarez; Pilar Peris; Nuria Guañabens; S Vidal; Llorenç Quintó; Ana Monegal; Francesca Pons; Antonio M Ballesta; José Muñoz-Gómez
Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
Rheumatology (Oxford, England) 2004;43(7):869-74.
2004: Xavier Filella; David Truan; Juan Alcover; Llorenç Quintó; Rafael Molina; Pilar Luque; Francisca Coca; Antonio M Ballesta
Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.
Urology 2004;63(6):1100-3; discussion 1103-4.
2004: Nuria Laso; Sergi Mas; M Jose Lafuente; Xavier Casterad; Manuel Trias; Antonio M Ballesta; Rafael Molina; Jordi Salas; Carlos Ascaso; Shichun Zheng; John K Wiencke; Amalia Lafuente
Decrease in specific micronutrient intake in colorectal cancer patients with tumors presenting Ki-ras mutation.
Anticancer research 2004;24(3b):2011-20.
2004: Xavier Filella; David Truan; Juan Alcover; Rafael Molina; Pilar Luque; Francisca Coca; Antonio M Ballesta
[Usefulness of PSA and its fractions in the diagnosis of prostate cancer].
Medicina clínica 2004;122(7):241-4.
2004: Sergi Mas; Xavier Casterad; Nuria Laso; M Jose Lafuente; R Panades; A Calleja; S Hernandez; D Turuguet; Ramon Deulofeu; Antonio M Ballesta; Carlos Ascaso; Amalia Lafuente
Concentration of hydroxyproline in blood: a biological marker in occupational exposure to asbestos and its relationship with Pi*Z and Pi*S polymorphism in the alpha-1 antitrypsin gene.
American journal of industrial medicine 2004;45(2):186-93.
2004: Rafael Molina; Jose M Auge; Julian Alicarte; Xavier Filella; Núria Viñolas; Antonio M Ballesta
Pro-gastrin-releasing peptide in patients with benign and malignant diseases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(1-2):56-61.
2004: Luisa Alvarez; Jose-Vicente Torregrosa; Pilar Peris; Ana Monegal; Josep Lluís Bedini; Maria-Jesús Martinez De Osaba; Xavier Filella; Gloria Martin; Carmen Ricos; Federico Oppenheimer; Antonio M Ballesta
Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover.
Journal of bone and mineral metabolism 2004;22(3):254-9.
2003: Carlos Miret; Rafael Molina; Xavier Filella; Mario García-Carrasco; Gisela Claver; Miguel Ingelmo; Antonio M Ballesta; José Font
Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2003;24(4):185-8.
2003: Rafael Molina; Xavier Filella; Gabriel Zanon; Jaume Pahisa; Julian Alicarte; M Munoz; B Farrus; Antonio M Ballesta
Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.
Anticancer research 2003;23(2A):1043-50.
2003: Rafael Molina; Xavier Filella; Julian Alicarte; Gabriel Zanon; Jaume Pahisa; M Munoz; B Farrus; Antonio M Ballesta
Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancer.
Anticancer research 2003;23(2A):1035-41.
2003: Luisa Alvarez; Pilar Peris; Nuria Guañabens; S Vidal; Inmaculada Ros; Francesca Pons; X Filella; Ana Monegal; José Muñoz-Gomez; Antonio M Ballesta
Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
Arthritis and rheumatism 2003;48(3):824-8.
2003: Sergi Mas; Nuria Laso; Maria Jose Lafuente; Amalia Lafuente; Rafael Molina; Antonio M Ballesta; Shichun Zheng; John Kevin Wiencke
Cancer, genes, and catechol estrogen metabolites.
International journal of clinical oncology 2003;8(1):65-6.
2002: M Jose Lafuente; Xavier Casterad; Nuria Laso; Sergi Mas; R Panades; A Calleja; S Hernandez; D Turuguet; Antonio M Ballesta; Carlos Ascaso; Amalia Lafuente
Pi*S and Pi*Z alpha 1 antitrypsin polymorphism and the risk for asbestosis in occupational exposure to asbestos.
Toxicology letters 2002;136(1):9-17.
2002: Nuria Laso; M Jose Lafuente; Sergi Mas; Manuel Trias; Carlos Ascaso; Rafael Molina; Antonio M Ballesta; F Rodriguez; Amalia Lafuente
Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer.
Anticancer research 2002;22(6A):3399-403.
2002: Roser Gibanel; María José Ribal; Xavier Filella; Antonio M Ballesta; Rafael Molina; Antonio Alcaraz; J B Alcover
BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder.
Anticancer research 2002;22(2B):1157-60.
2002: Rafael Molina; Javier Navarro; Xavier Filella; Teresa Castel; Antonio M Ballesta
S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2002;23(1):39-44.
2002: Pilar Peris; Luisa Alvarez; Ana Monegal; Nuria Guañabens; Magdalena Durán; Mónica Echevarría; Inmaculada Ros; Antonio M Ballesta; José Muñoz-Gómez
Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
Journal of bone and mineral metabolism 2002;20(2):116-20.
2001: Luisa Alvarez; Nuria Guañabens; Pilar Peris; S Vidal; Inmaculada Ros; Ana Monegal; Josep Lluís Bedini; Ramon Deulofeu; Francesca Pons; José Muñoz-Gomez; Antonio M Ballesta
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.
Bone 2001;29(5):447-52.
2001: Xavier Filella; Juan Alcover; Juan M Corral; Rafael Molina; P Beardo; Antonio M Ballesta
Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.
Anticancer research 2001;21(5):3717-20.
2001: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
Anticancer research 2001;21(4B):3053-9.
2001: Anna Colell; Carmen García-Ruiz; J Roman; Antonio M Ballesta; José C Fernández-Checa
Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-kappa B-dependent survival pathway.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(6):1068-70.
2001: Albert Pares; Nuria Guañabens; Luisa Alvarez; MJ de Osaba; Josep Oriola; Francesca Pons; Llorenç Caballería; Ana Monegal; G Salvador; J Jo; Pilar Peris; F Rivera; Antonio M Ballesta; Juan Rodés
Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2001;33(3):554-60.
2001: Xavier Filella; Rafael Molina; Juan Alcover; Francisca Coca; MA Zarco; Antonio M Ballesta
Influence of AFP, CEA and PSA on the in vitro production of cytokines.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2001;22(2):67-71.
2000: Pilar Peris; Luisa Alvarez; Josep Oriola; Nuria Guañabens; Ana Monegal; MJ de Osaba; J Jo; Francesca Pons; Antonio M Ballesta; José Muñoz-Gómez
Collagen type Ialpha1 gene polymorphism in idiopathic osteoporosis in men.
Rheumatology (Oxford, England) 2000;39(11):1222-5.
2000: Shichun Zheng; P Chen; A McMillan; Amalia Lafuente; M Jose Lafuente; Antonio M Ballesta; Manuel Trias; John K Wiencke
Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors.
Carcinogenesis 2000;21(11):2057-64.
2000: M Jose Lafuente; Xavier Casterad; Manuel Trias; Carlos Ascaso; Rafael Molina; Antonio M Ballesta; Shichun Zheng; John K Wiencke; Amalia Lafuente
NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
Carcinogenesis 2000;21(10):1813-9.
2000: Xavier Filella; Juan Alcover; MA Zarco; P Beardo; Rafael Molina; Antonio M Ballesta
Analysis of type T1 and T2 cytokines in patients with prostate cancer.
The Prostate 2000;44(4):271-4.
2000: L Alvarez; C RicOs; Pilar Peris; N GuaNabens; Ana Monegal; F Pons; Antonio M Ballesta
Components of biological variation of biochemical markers of bone turnover in Paget's bone disease.
Bone 2000;26(6):571-6.
2000: Xavier Filella; Juan Alcover; Rafael Molina; Juan M Corral; P Carretero; Antonio M Ballesta
Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia .
The Prostate 2000;42(3):181-5.
1999: Xavier Filella; Juan Alcover; Llorenç Quintó; Rafael Molina; X Bosch-Capblanch; P Carretero; Antonio M Ballesta
Evaluation of a multivariate prostate-specific antigen and percentage of free prostate-specific antigen logistic regression model in the diagnosis of prostate cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1999;20(6):312-8.
1999: Pilar Peris; Luisa Alvarez; Ana Monegal; Nuria Guañabens; Magdalena Durán; Francesca Pons; Ma Jesús Martínez de Osaba; Mónica Echevarría; Antonio M Ballesta; José Muñoz-Gómez
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
Bone 1999;25(3):349-53.
1999: Carlos Miret; Josep Font; Rafael Molina; Mario Garcia-Carrasco; Xavier Filella; M Ramos; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Bcl-2 oncogene (B cell lymphoma/leukemia-2) levels correlate with systemic lupus erythematosus disease activity.
Anticancer research 1999;19(4B):3073-6.
1999: Rafael Molina; B Farrus; Xavier Filella; J Jo; Gabriel Zanón; Jaume Pahisa; ML Latre; Montserrat Muñoz; Antonio M Ballesta
Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Anticancer research 1999;19(4A):2557-62.
1999: Rafael Molina; J Jo; Xavier Filella; Gabriel Zanón; B Farrus; Montserrat Muñoz; ML Latre; Jaume Pahisa; Martín Velasco; P Fernandez; Jordi Estapé; Antonio M Ballesta
C-erbB-2, CEA and CA 15.3 serum levels in the early diagnosis of recurrence of breast cancer patients.
Anticancer research 1999;19(4A):2551-5.
1999: Francesca Pons; L Alvarez; Pilar Peris; Nuria Guañabens; Sergi Vidal-Sicart; Ana Monegal; Javier Pavía; Antonio M Ballesta; J Muños-Gómez; R Herranz
Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
Nuclear medicine communications 1999;20(6):525-8.
1999: L Aĺvarez; Nuria Guañabens; Pilar Peris; Antonio M Ballesta
[The clinical utility of biochemical markers of bone remodeling].
Medicina clínica 1999;112(13):517-8.
1999: Luisa Alvarez; Pilar Peris; Josep Lluís Bedini; Albert Pares; Ana Monegal; Nuria Guañabens; E Mas; C Aibar; Antonio M Ballesta
High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: relevance as a marker of bone resorption in jaundiced patients.
Calcified tissue international 1999;64(4):301-3.
1999: Marc Net; Juan Carlos Garcia-Valdecasas; Ramon Deulofeu; X Gonzalez; Jordi Palacin; Raul Almenara; Ricard Valero; MA Lopez-Boado; J Angás; M Elena; Antonio M Ballesta; Josep Visa
S-adenosyl L-methionine effect on hepatic allografts procured from non-heart-beating donor pigs.
Transplantation proceedings 1999;31(1-2):1063-4.
1999: Elena Casals; C Aibar; J M Martínez; Antoni Borrell; Anna Soler; Julia Ojuel; Antonio M Ballesta; Albert Fortuny
First-trimester biochemical markers for Down syndrome.
Prenatal diagnosis 1999;19(1):8-11.
1998: Xavier Filella; Joan Bladé; Silvia Montoto; Rafael Molina; Francisca Coca; Emili Montserrat; Antonio M Ballesta
Impaired production of interleukin 6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma.
Cytokine 1998;10(12):993-6.
1998: Rafael Molina; J Jo; Xavier Filella; Gabriel Zanon; Jaume Pahisa; M Mu noz; B Farrus; ML Latre; C Escriche; J Estape; Antonio M Ballesta
c-erbB-2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value.
Breast cancer research and treatment 1998;51(2):109-19.
1998: Amalia Lafuente; A Rodriguez; Roser Gibanel; M Jose Lafuente; M Alonso; Rafael Molina; Antonio M Ballesta; P Carretero
Limitations in the use of glutathione S-transferase P1 in urine as a marker for bladder cancer.
Anticancer research 1998;18(5B):3771-2.
1998: C Sanllehy; Elena Casals; C Rodriguez-Villar; Daniel Zambón; Julia Ojuel; Antonio M Ballesta; Emilio Ros
Lack of interaction of apolipoprotein E phenotype with the lipoprotein response to lovastatin or gemfibrozil in patients with primary hypercholesterolemia.
Metabolism: clinical and experimental 1998;47(5):560-5.
1998: Nuria Guañabens; Albert Pares; Luisa Alvarez; Ma Jesús Martínez de Osaba; Ana Monegal; Pilar Peris; Antonio M Ballesta; Juan Rodés
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(4):731-8.
1998: M Elena; M Pérez; M Jansà; R Déulofeu; Enric Esmatjes; N Schinca; E Mas; R Molina; Antonio M Ballesta
[Content of carbohydrates and trace elements in a group of non-alcoholic drinks].
Medicina clínica 1998;110(10):365-9.
1998: Carlos Miret; Josep Font; Rafael Molina; Xavier Filella; J Vivancos; FJ Muñoz-Rodriguez; Ricard Cervera; Antonio M Ballesta; Miguel Ingelmo
Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Anticancer research 1998;18(2B):1341-4.
1998: Núria Viñolas; Rafael Molina; Maica Galán; F Casas; MA Callejas; Xavier Filella; Juan J Grau; Antonio M Ballesta; J Estape
Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.
Anticancer research 1998;18(1B):631-4.
1998: Rafael Molina; M A Segui; Miguel Angel Climent; Joaquim Bellmunt; J Albanelll; M Fernandez; Xavier Filella; J Jo; N Gimenez; E Iglesias; M Miralles; C Alonso; G Peiro; E Perez-Picañol; Antonio M Ballesta
p53 oncoprotein as a prognostic indicator in patients with breast cancer.
Anticancer research 1998;18(1B):507-11.
1998: Amalia Lafuente; M Maristany; C Arias; A Cuchi; M Jose Lafuente; Rafael Molina; Antonio M Ballesta; J Trasserra
Glutathione and glutathione S-transferases in human squamous cell carcinomas of the larynx and GSTM1 dependent risk.
Anticancer research 1998;18(1A):107-11.
1997: Anna Colell; Carmen García-Ruiz; Albert Morales; Antonio M Ballesta; Murad Ookhtens; J Rodés; Neil Kaplowitz; José C Fernández-Checa
Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-L-methionine.
Hepatology (Baltimore, Md.) 1997;26(3):699-708.
1997: Xavier Filella; Juan Alcover; Rafael Molina; A Rodríguez; P Carretero; Antonio M Ballesta
Clinical evaluation of free PSA/total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1226-9.
1997: Luisa Alvarez; Pilar Peris; Francesca Pons; Nuria Guañabens; R Herranz; Ana Monegal; Josep Lluís Bedini; Ramon Deulofeu; Ma Jesús Martínez de Osaba; José Muñoz-Gómez; Antonio M Ballesta
Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.
Arthritis and rheumatism 1997;40(3):461-8.
1997: Xavier Filella; Juan Alcover; Rafael Molina; A Rodríguez; P Carretero; Antonio M Ballesta
Free and total PSA in the diagnosis of prostate cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(6):332-40.
1997: Rafael Molina; J Jo; Xavier Filella; J Bruix; A Castells; M Hague; Antonio M Ballesta
Serum levels of C-erbB-2 (HER-2/neu) in patients with malignant and non-malignant diseases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(3):188-96.
1996: Xavier Filella; Rafael Molina; Juan Alcover; P Carretero; Antonio M Ballesta
Detection of nonprostatic PSA in serum and nonserum samples from women.
International journal of cancer. Journal international du cancer 1996;68(4):424-7.
1996: Xavier Filella; Rafael Molina; Juan Alcover; V Menéndez; N Giménez; J Jo; P Carretero; Antonio M Ballesta
Prostate-specific antigen detection by ultrasensitive assay in samples from women.
The Prostate 1996;29(5):311-6.
1996: Nuria Durany; E Carballo; James A Joseph; J L Bedini; Ramon Bartrons; Antonio M Ballesta; José Carreras
Activity of phosphoglycerate mutase and its isoenzymes in serum after acute myocardial infarction.
Clinical molecular pathology 1996;49(5):M298-300.
1996: Rafael Molina; J Jo; Gabriel Zanón; Xavier Filella; B Farrus; Montserrat Muñoz; M L Latre; Jaume Pahisa; M Velasco; P Fernandez; Jordi Estapé; Antonio M Ballesta
Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.
British journal of cancer 1996;74(7):1126-31.
1996: Rafael Molina; J Jo; Xavier Filella; G Zanon; Jaume Pahisa; Montserrat Muñoz; B Farrus; M L Latre; N Gimenez; M Hage; J Estape; Antonio M Ballesta
C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.
Anticancer research 1996;16(4B):2295-300.
1996: Xavier Filella; V Menendez; Rafael Molina; Juan Alcover; P Carretero; Antonio M Ballesta
TPA prognostic value in superficial bladder cancer.
Anticancer research 1996;16(4B):2173-5.
1996: Xavier Filella; R Molina; Antonio M Ballesta; M J Gil; C Allepuz; L A Rioja
Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study.
European journal of cancer (Oxford, England : 1990) 1996;32A(7):1125-8.
1996: Eduardo Targarona; M J Pons; Carmen Balagué; JJ Espert; Antonio Moral; J Martínez; jose maria Gaya; X Filella; F Rivera; Antonio M Ballesta; Manuel Trías
Acute phase is the only significantly reduced component of the injury response after laparoscopic cholecystectomy.
World journal of surgery 1996;20(5):528-33; discussion 533-4.
1996: Elena Casals; Albert Fortuny; Gedis Grudzinskas; Y Suzuki; B Teisner; C Comas; C Sanllehy; Julia Ojuel; Antoni Borrell; Anna Soler; Antonio M Ballesta
First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and beta-hCG.
Prenatal diagnosis 1996;16(5):405-10.
1996: Xavier Filella; Antonio M Ballesta; M Fox; H Mitchell; Rafael Molina; P Pürstner; H Thome
Multicentre clinical evaluation of the COBAS CORE CEA, CA 125 II and PSA tumor marker assays.
The International journal of biological markers 1996;11(1):40-5.
1996: Rafael Molina; M D Torres; M Moragas; J Perez-Villa; Xavier Filella; J Jo; B Farrus; N Giménez; J Traserra; Antonio M Ballesta
Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(2):81-9.
1996: Xavier Filella; Juan Alcover; Rafael Molina; W Carrere; P Carretero; Antonio M Ballesta
Usefulness of prostate-specific antigen density as a diagnostic test of prostate cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1996;17(1):20-6.
1995: Xavier Filella; Juan Alcover; Rafael Molina; N Giménez; A Rodríguez; J Jo; P Carretero; Antonio M Ballesta
Clinical usefulness of free PSA fraction as an indicator of prostate cancer.
International journal of cancer. Journal international du cancer 1995;63(6):780-4.
1995: Xavier Filella; R Molina; Juan Alcover; Elena Casals; Francisco Carmona; Antonio M Ballesta
Prostate specific antigen in non-serum samples from women.
The International journal of biological markers 1995;10(4):238-9.
1995: V Menéndez; Xavier Filella; Juan Alcover; Rafael Molina; Antonio M Ballesta; P Carretero
[Role of tissue polypeptide antigen as a marker in bladder cancer].
Actas urologicas españolas 1995;19(6):441-4.
1995: G Borras; Rafael Molina; J Xercavins; Antonio M Ballesta; J Iglesias
Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix.
Gynecologic oncology 1995;57(2):205-11.
1995: Juan Alcover; J Filella; J R Vendrell; R Molina; Antonio M Ballesta; P Carretero
[The diagnostic utility of PSA density].
Actas urologicas españolas 1995;19(3):192-5.
1995: Luisa Alvarez; Nuria Guañabens; Pilar Peris; Ana Monegal; Josep Lluís Bedini; R Deulofeu; M J Martinez de Osaba; José Muñoz-Gomez; Francisca Rivera-Fillat; Antonio M Ballesta
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1995;10(3):458-65.
1995: Rafael Molina; M D Torres; M Moragas; Xavier Filella; J Jo; N Giménez; J Traserra; Antonio M Ballesta
Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.
Anticancer research 1995;15(2):479-84.
1995: Antonio M Ballesta; Rafael Molina; Xavier Filella; J Jo; N Giménez
Carcinoembryonic antigen in staging and follow-up of patients with solid tumors.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1995;16(1):32-41.
1995: Carmen García-Ruiz; Albert Morales; Anna Colell; Antonio M Ballesta; Juan Rodés; Neil Kaplowitz; José C Fernández-Checa
Feeding S-adenosyl-L-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes.
Hepatology (Baltimore, Md.) 1995;21(1):207-14.
1994: Jordi Gratacós; Antonio Collado; Xavier Filella; Raimon Sanmartí; Juan D Cañete; J Llena; R Molina; Antonio M Ballesta; José Muñoz-Gómez
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.
British journal of rheumatology 1994;33(10):927-31.
1994: Carmen García-Ruiz; Albert Morales; Antonio M Ballesta; Juan Rodés; Neil Kaplowitz; José C Fernández-Checa
Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes.
The Journal of clinical investigation 1994;94(1):193-201.
1994: E A Mas; Josep Lluís Bedini; Francisco Carmona; Vicenç Cararach; A Gallart; Antonio M Ballesta
False-negative urinary pregnancy test in a woman with a combined pancreas-kidney transplant.
Clinical chemistry 1994;40(6):943-4.
1994: Rafael Molina; C Agusti; J M Mañe; Xavier Filella; J Jo; J Joseph; N Giménez; Jordi Estapé; Antonio M Ballesta
CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels.
The International journal of biological markers 1994;9(2):96-101.
1994: Xavier Filella; Rafael Molina; J M Piqué; Juan Carlos Garcia-Valdecasas; Juan J Grau; F Novell; Emiliano Astudillo; A de Lacy; M Daniels; Antonio M Ballesta
Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(1):1-6.
1994: Rafael Molina; C Agusti; Xavier Filella; J Jo; J Joseph; N Giménez; Antonio M Ballesta
Study of a new tumor marker, CYFRA 21-1, in malignant and nonmalignant diseases.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1994;15(6):318-25.
1994: Xavier Filella; J Fuster; Rafael Molina; Juan J Grau; J C García-Valdecasas; L Grande; Jordi Estapé; Antonio M Ballesta
TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.
Acta oncologica (Stockholm, Sweden) 1994;33(7):747-51.
1993: Juan Alcover; Xavier Filella; M A Barranco; Rafael Molina; Antonio M Ballesta; P Carretero
False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy.
Archivio italiano di urologia, andrologia : organo ufficiale [di] Società italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia 1993;65(6):657-60.
1993: Rafael Molina; X Filelia; M A Segui; M A Climent; E Pérez-Picañol; C Alonso; J Jo; Belén Ojeda; A K Tandon; Antonio M Ballesta
Oncogenic proteins and prognostic correlations in breast cancer.
In vivo (Athens, Greece) 1993;7(6B):585-9.
1993: Rafael Molina; J Jo; Xavier Filella; G Zanon; Juan J Grau; J Joseph; Josep Lluís Bedini; Albert Biete; Antonio M Ballesta
Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.
The International journal of biological markers 1993;8(2):113-23.
1992: G Borras; Rafael Molina; J Xercavins; Antonio M Ballesta; X Iglesias
Squamous cell carcinoma antigen in cervical cancer.
European journal of gynaecological oncology 1992;13(5):414-8.
1992: Xavier Filella; Rafael Molina; J Jo; Josep Lluís Bedini; J Joseph; Antonio M Ballesta
Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
Bulletin du cancer 1992;79(3):271-7.
1992: Rafael Molina; Belén Ojeda; Xavier Filella; G Borras; J Jo; E Mas; J J Lopez; Antonio M Ballesta
A prospective study of tumor markers CA 125 and CA 19.9 in patients with epithelial ovarian carcinomas.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1992;13(5-6):278-86.
1991: Rafael Molina; Xavier Filella; Jordi Bruix; P Mengual; Jaime Bosch; Xavier Calvet; J Jo; Antonio M Ballesta
Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.
Clinical chemistry 1991;37(8):1379-83.
1991: Xavier Filella; Rafael Molina; P J Mengual; J Jo; Antonio M Ballesta
Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(3):158-61.
1991: Aleix Cases; Xavier Filella; Rafael Molina; Antonio M Ballesta; J Lopez-Pedret; L Revert
Tumor markers in chronic renal failure and hemodialysis patients.
Nephron 1991;57(2):183-6.
1991: Xavier Filella; Rafael Molina; J Jo; E Mas; Antonio M Ballesta
Serum phosphohexose isomerase activities in patients with colorectal cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1991;12(6):360-7.
1990: Xavier Filella; Rafael Molina; Josep Lluís Bedini; J Jo; J Joseph; Antonio M Ballesta
Clinical usefulness of CEA as tumor marker in patients with colorectal cancer.
The Journal of nuclear medicine and allied sciences 1990;34(4 Suppl):107-10.
1990: Xavier Filella; Aleix Cases; Rafael Molina; J Jo; Josep Lluís Bedini; L Revert; Antonio M Ballesta
Tumor markers in patients with chronic renal failure.
The International journal of biological markers 1990;5(2):85-8.
1990: Rafael Molina; Xavier Filella; M D Torres; Antonio M Ballesta; P Mengual; Aleix Cases; A Balaque
SCC antigen measured in malignant and nonmalignant diseases.
Clinical chemistry 1990;36(2):251-4.
1990: Rafael Molina; Xavier Filella; M Herranz; M Prats; A Velasco; G Zanon; M J Martinez-Osaba; Antonio M Ballesta
Biochemistry of cyst fluid in fibrocystic disease of the breast. Approach to classification and understanding of the mechanism of formation.
Annals of the New York Academy of Sciences 1990;586():29-42.
1990: Rafael Molina; Xavier Filella; P Mengual; M Prats; G Zanon; M Daniels; Antonio M Ballesta
MCA in patients with breast cancer: correlation with CEA and CA15-3.
The International journal of biological markers 1990;5(1):14-21.
1990: Xavier Filella; Rafael Molina; J Jo; B Umbert; Josep Lluís Bedini; Antonio M Ballesta
Clinical usefulness of prostate-specific antigen and prostatic acid phosphatase in patients with prostatic cancer.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1990;11(6):289-94.
1989: Rafael Molina; P Santabarbara; Xavier Filella; P Mengual; Antonio M Ballesta; A Balague
Relationship of CA 125 and CA 19.9 with lung carcinoma histological subtype: preliminary study.
The International journal of biological markers 1989;4(4):215-20.
1989: Antonio M Ballesta; Xavier Calvet; Xavier Filella; Jordi Bruix; C Bru; R Molina; Juan Rodes
Alpha-fetoprotein in the early diagnosis of hepatocellular carcinoma.
The Journal of nuclear medicine and allied sciences 1989;33(3 Suppl):39-41.
1989: Josep Lluís Bedini; Elena Casals; C Sanllehy; Xavier Filella; E Mas; Rafael Molina; Antonio M Ballesta
A new immunonephelometric method for amniotic fluid alpha-fetoprotein measurement.
The Journal of nuclear medicine and allied sciences 1989;33(3 Suppl):135-7.
1988: J Iglesias; G Borras; J M Lailla; A Fortuny; Rafael Molina; Antonio M Ballesta; J Sentís
Total LDH and its isoenzymes in gynecological malignancies and other gynecological conditions.
European journal of gynaecological oncology 1988;9(1):32-5.
1985: Elena Casals; M Elena; R Molina; Antonio M Ballesta
Improved separation of alpha-amylase isoenzymes.
Clinical chemistry 1985;31(6):1073.
1982: A Martinez-Vea; José M Gatell; F Segura; C Heiman; M Elena; Antonio M Ballesta; M R Mundo
Diagnostic value of tumoral markers in serous effusions: carcinoembryonic antigen, alpha1-acidglycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta 2-microglobulin.
Cancer 1982;50(9):1783-8.
1982: J P Marques-Pereira; E Montserrat; C Rozman; Antonio M Ballesta; J L Aguilar; M Elena
[Serum beta-2 microglobulin in chronic lymphatic leukemia in relation to clinical staging].
Sangre 1982;27(5):891-8.
1982: E Montserrat; J P Marques-Pereira; C Rozman; Antonio M Ballesta; J L Aguilar; M Elena
Serum beta-2 microglobulin in chronic lymphocytic leukaemia.
Clinical and laboratory haematology 1982;4(3):323-5.
1982: J Cabrera; V Arroyo; Antonio M Ballesta; A Rimola; J Gual; M Elena; Juan Rodes
Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.
Gastroenterology 1982;82(1):97-105.